Medication Adherence Measures: An Overview

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Lam, Wai Yin ^a   Fresco, Paula ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ASSESSMENT OF HUMANS; BRIEF MEDICATION QUESTIONNAIRE; CHRONIC DISEASE; CLINICAL ASSESSMENT; CONTINUOUS INTERVAL MEASURE OF MEDICATION GAP; CONTINUOUS MULTIPLE INTERVAL MEASURE OF MEDICATION ACQUISITION; CONTINUOUS MULTIPLE INTERVAL MEASURE OF MEDICATION GAP; CONTINUOUS SINGLE INTERVAL MEASURE OF MEDICATION ACQUISITION; COST EFFECTIVENESS ANALYSIS; DATA BASE; DEVELOPED COUNTRY; DRUG EXPOSURE; DRUG METABOLISM; DRUG PACKAGING; ELECTRONIC MEDICATION PACKAGING; ELECTRONIC MEDICATION PACKAGING DEVICE; ELECTRONIC PRESCRIBING; GENERAL MEDICAL DEVICE; HEALTH CARE COST; HILL BONE COMPLIANCE SCALE; HUMAN; INTERVIEW; MATHEMATICAL PARAMETERS; MEDICAL RECORD REVIEW; MEDICATION ADHERENCE QUESTIONNAIRE; MEDICATION ADHERENCE REPORT SCALE; MEDICATION COMPLIANCE; MEDICATION EVENTS MONITORING SYSTEM; MEDICATION POSSESSION RATIO; META ANALYSIS (TOPIC); MICROELECTROMECHANICAL SYSTEM; MORISKY MEDICATION ADHERENCE SCALE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; PHARMACOLOGICAL PARAMETERS; PILL; PRESCRIPTION; QUESTIONNAIRE; REVIEW; SELF EFFICACY FOR APPROPRIATE MEDICATION USE SCALE; SELF REPORT; SYSTEMATIC REVIEW (TOPIC); ECONOMICS;

CHRONIC DISEASE; HEALTH CARE COSTS; HUMANS; MEDICATION ADHERENCE;

EID: 84946058446     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/217047     Document Type: Review

References (57)

1. E. Sabaté, Adherence to Long-Term Therapies: Evidence for Action, World Health Organization, Geneva, Switzerland, 2003.
2. M. T. Brown and J. K. Bussell, "Medication adherence:WHO cares?"Mayo Clinic Proceedings, vol. 86, no. 4, pp. 304-314, 2011.
3. M. J. Johnson, M. Williams, and E. S. Marshall, "Adherent and nonadherent medication-taking in elderly hypertensive patients," Clinical Nursing Research, vol. 8, no. 4, pp. 318-335, 1999.
4. S. M. Lavsa, A. Holzworth, and N. T. Ansani, "Selection of a validated scale formeasuring medication adherence," Journal of the American Pharmacists Association, vol. 51, no. 1, pp. 90-94, 2011.
5. B. L. Svarstad, B. A. Chewning, B. L. Sleath, and C. Claesson, "The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence," Patient Education & Counseling, vol. 37, no. 2, pp. 113-124, 1999.
6. P. J. McDonnell, M. R. Jacobs, H. A. Monsanto, and J.-M. Kaiser, "Hospital admissions resulting from preventable adverse drug reactions," Annals of Pharmacotherapy, vol. 36, no. 9, pp. 1331-1336, 2002.
7. L. Osterberg and T. Blaschke, "Adherence to medication," The New England Journal of Medicine, vol. 353, no. 5, pp. 487-497, 2005.
8. B. Vrijens, S. de Geest, D. A. Hughes et al., "A new taxonomy for describing and defining adherence to medications," British Journal of Clinical Pharmacology, vol. 73, no. 5, pp. 691-705, 2012.
9. M. A. Fischer, M. R. Stedman, J. Lii et al., "Primary medication non-adherence: analysis of 195,930 electronic prescriptions," Journal of General Internal Medicine, vol. 25, no. 4, pp. 284-290, 2010.
10. M. D. Solomon and S. R. Majumdar, "Primary non-adherence of medications: lifting the veil on prescription-filling behaviors," Journal of General Internal Medicine, vol. 25, no. 4, pp. 280-281, 2010.
11. E. Lehane and G. McCarthy, "Medication non-adherence-exploring the conceptual mire," International Journal of Nursing Practice, vol. 15, no. 1, pp. 25-31, 2009.
12. D. L. Sackett, R. B. Haynes, and E. S. Gibson, "Patient compliance with antihypertensive regimens," Patient Counselling and Health Education, vol. 1, no. 1, pp. 18-21, 1978.
13. E. Vermeire, H. Hearnshaw, P. Van Royen, and J. Denekens, "Patient adherence to treatment: three decades of research. A comprehensive review," Journal of Clinical Pharmacy and Therapeutics, vol. 26, no. 5, pp. 331-342, 2001.
14. J. F. Steiner and M. A. Earnest, "The language of medicationtaking," Annals of Internal Medicine, vol. 132, no. 11, pp. 926-930, 2000.
15. K. C. Farmer, "Methods formeasuring and monitoringmedication regimen adherence in clinical trials and clinical practice," Clinical Therapeutics, vol. 21, no. 6, pp. 1074-1090, 1999.
16. F. Hurley, J. Cramer, and B. Spilker, "Statistical approach to subgroup analyses: patient compliance data and clinical outcomes," in Patient Compliance in Medical Practice and Clinical Trials, pp. 243-250, Raven Press, 1991.
17. M. Z. Vitolins, C. S. Rand, S. R. Rapp, P. M. Ribisl, and M. A. Sevick, "Measuring adherence to behavioral and medical interventions," Controlled Clinical Trials, vol. 21, no. 5, supplement, pp. 188S-194S, 2000.
18. D. I. Velligan, M. Wang, P. Diamond et al., "Relationships among subjective and objective measures of adherence to oral antipsychotic medications," Psychiatric Services, vol. 58, no. 9, pp. 1187-1192, 2007.
19. S. A. Vik, C. J. Maxwell, and D. B. Hogan, "Measurement, correlates, and health outcomes of medication adherence among seniors," Annals of Pharmacotherapy, vol. 38, no. 2, pp. 303-312, 2004.
20. M. A. Dew, A. D. Dabbs, L. Myaskovsky et al., "Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation," Transplantation, vol. 88, no. 5, pp. 736-746, 2009.
21. P. M. Ho, C. L. Bryson, and J. S. Rumsfeld, "Medication adherence: its importance in cardiovascular outcomes," Circulation, vol. 119, no. 23, pp. 3028-3035, 2009.
22. B. Jimmy and J. Jose, "Patient medication adherence: measures in daily practice," Oman Medical Journal, vol. 26, no. 3, pp. 155-159, 2011.
23. E. Diaz, H. B. Levine, M. C. Sullivan et al., "Use of the medication event monitoring system to estimate medication compliance in patients with schizophrenia," Journal of Psychiatry and Neuroscience, vol. 26, no. 4, pp. 325-329, 2001.
24. J. A. Cramer, R. D. Scheyer, and R. H. Mattson, "Compliance declines between clinic visits," Archives of Internal Medicine, vol. 150, no. 7, pp. 1509-1510, 1990.
25. A. C. Modi, L. M. Ingerski, J. R. Rausch, T. A. Glauser, and D. Drotar, "White coat adherence over the first year of therapy in pediatric epilepsy," The Journal of Pediatrics, vol. 161, no. 4, pp. 695-699.e1, 2012.
26. R. S. Downie, Clinical Judgement: Evidence in Practice, editedby: J. Macnaughton, F. Randall, Oxford University Press, Oxford, UK, 2000.
27. J. F. Steiner and A. V. Prochazka, "The assessment of refill compliance using pharmacy records: methods, validity, and applications," Journal of Clinical Epidemiology, vol. 50, no. 1, pp. 105-116, 1997.
28. L. M. Hess, M. A. Raebel, D. A. Conner, and D. C. Malone, "Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures," Annals of Pharmacotherapy, vol. 40, no. 7-8, pp. 1280-1288, 2006.
29. J. Barner, Medication Adherence: Focus on Secondary Database Analysis, ISPOR Student Forum, 2010.
30. M. M. Kitahata, S. D. Reed, P.W. Dillingham et al., "Pharmacybased assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death," International Journal of STD and AIDS, vol. 15, no. 12, pp. 803-810, 2004.
31. M. Krousel-Wood, E. Holt, C. Joyce et al., "Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO)," Journal of Hypertension, vol. 33, no. 2, pp. 412-420, 2015.
32. S. E. Andrade, K. H. Kahler, F. Frech, and K. A. Chan, "Methods for evaluation of medication adherence and persistence using automated databases," Pharmacoepidemiology and Drug Safety, vol. 15, no. 8, pp. 565-574, 2006.
33. D. R. Vanderpoel, M. A. Hussein, T. Watson-Heidari, and A. Perry, "Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis," Clinical Therapeutics, vol. 26, no. 12, pp. 2066-2075, 2004.
34. M. R. DiMatteo, P. J. Giordani, H. S. Lepper, and T.W. Croghan, "Patient adherence and medical treatment outcomes: a metaanalysis," Medical Care, vol. 40, no. 9, pp. 794-811, 2002.
35. K.D. Checchi, K. F. Huybrechts, J. Avorn, and A. S. Kesselheim, "Electronic medication packaging devices and medication adherence: a systematic review," The Journal of the American Medical Association, vol. 312, no. 12, pp. 1237-1247, 2014.
36. H. A. W. van Onzenoort, W. J. Verberk, A. G. H. Kessels et al., "Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension," The American Journal of Hypertension, vol. 23, no. 2, pp. 149-154, 2010.
37. J. Y. Lee, J.W. Kusek, P. G. Greene et al., "Assessing medication adherence by pill count and electronic monitoring in the African American study of kidney disease and hypertension (AASK) pilot study," American Journal of Hypertension, vol. 9, no. 8, pp. 719-725, 1996.
38. T.-M. Nguyen, A. L. Caze, and N. Cottrell, "What are validated self-report adherence scales really measuring?: a systematic review," British Journal of Clinical Pharmacology, vol. 77, no. 3, pp. 427-445, 2014.
39. D. E. Morisky, A. Ang, M. Krousel-Wood, and H. J. Ward, "Predictive validity of a medication adherence measure in an outpatient setting," Journal of Clinical Hypertension, vol. 10, no. 5, pp. 348-354, 2008.
40. R. J. Straka, J. T. Fish, S. R. Benson, and J. T. Suh, "Patient selfreporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug," Pharmacotherapy, vol. 17, no. 1, pp. 126-132, 1997.
41. W. R. Miller and S. Rollnick, Motivational Interviewing: Preparing People to Change Addictive Behavior, Guilford Press, 1991.
42. J. Kavookjian, "Motivational interviewing," in PSAP-VII Book 8 (Science and Practice of Pharmacotherapy), American College of Clinical Pharmacy, Lenexa, Kan, USA, 2011.
43. S. Rubak, A. Sandbæk, T. Lauritzen, and B. Christensen, "Motivational interviewing: a systematic review and meta-analysis," British Journal of General Practice, vol. 55, no. 513, pp. 305-312, 2005.
44. X. Tan, I. Patel, and J. Chang, "Review of the four item Morisky Medication Adherence Scale (MMAS-4) and eight item Morisky Medication Adherence Scale (MMAS-8)," Innovations in Pharmacy, vol. 5, no. 3, p. 165, 2014.
45. M. T. Kim, M.N. Hill, L. R. Bone, and D. M. Levine, "Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale," Progress in cardiovascular nursing, vol. 15, no. 3, pp. 90-96, 2000.
46. E. V. Lambert, K. Steyn, S. Stender, N. Everage, J. M. Fourie, and M. Hill, "Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting," Ethnicity and Disease, vol. 16, no. 1, pp. 286-291, 2006.
47. M. Krousel-Wood, C. Joyce, E.W. Holt et al., "Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension," Pharmacotherapy, vol. 33, no. 8, pp. 798-811, 2013.
48. M. Krousel-Wood, P. Muntner, A. Jannu, K. Desalvo, and R. N. Re, "Reliability of a medication adherence measure in an outpatient setting," The American Journal of the Medical Sciences, vol. 330, no. 3, pp. 128-133, 2005.
49. J. Culig and M. Leppée, "From Morisky to Hill-bone; selfreports scales for measuring adherence to medication," Collegium Antropologicum, vol. 38, no. 1, pp. 55-62, 2014.
50. B.A. Toll, S. A. McKee, D. J. Martin, P. Jatlow, and S. S.O'Malley, "Factor structure and validity of the Medication Adherence Questionnaire (MAQ) with cigarette smokers trying to quit," Nicotine and Tobacco Research, vol. 9, no. 5, pp. 597-605, 2007.
51. D. E. Morisky, L. W. Green, and D. M. Levine, "Concurrent and predictive validity of a self-reported measure of medication adherence," Medical Care, vol. 24, no. 1, pp. 67-74, 1986.
52. K. Thompson, J. Kulkarni, and A. A. Sergejew, "Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses," Schizophrenia Research, vol. 42, no. 3, pp. 241-247, 2000.
53. H. Liu, C. E. Golin, L. G. Miller et al., "A comparison study of multiple measures of adherence to HIV protease inhibitors," Annals of Internal Medicine, vol. 134, no. 10, pp. 968-977, 2001.
54. H. Bosworth, Improving Patient Treatment Adherence: A Clinician's Guide, Springer, New York, NY, USA, 2010.
55. M. A. Rapoff, Adherence to Pediatric Medical Regimens, Issues in Clinical Child Psychology, Springer, New York, NY, USA, 2nd edition, 2010.
56. A.C. Modi, C. S. Lim, N. Yu, D. Geller, M.H. Wagner, and A. L. Quittner, "A multi-method assessment of treatment adherence for children with cystic fibrosis," Journal of Cystic Fibrosis, vol. 5, no. 3, pp. 177-185, 2006.
57. M. M. Llabre, K. E. Weaver, R. E. Durán, M. H. Antoni, S. McPherson-Baker, and N. Schneiderman, "A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults," AIDS Patient Care and STDs, vol. 20, no. 10, pp. 701-711, 2006.